Clot questions over J&J and AstraZeneca vaccines
The European Medicines Agency (EMA) says blood clots should be listed as a "very rare" side effect of the Johnson & Johnson COVID vaccine. What we know about the jab and similar AstraZeneca shot:
AstraZeneca vaccine: what we know and what we don’t
A European Medicines Agency recommendation that a type of blood clot should be listed as a "very rare side effect" of the AstraZeneca jab stopped just short of saying there is a causal link with the vaccine
Questions about AstraZeneca jab linger
Fears of what is causing the 'highly untypical' blood clots seen in some people vaccinated against Covid-19 have undermined confidence in the AstraZeneca vaccine